What changed between these versions
A substantive modification. v3 changes the bill's short title to include "Mikaela Naylon" and revises the proposed allocation for the Medicare Improvement Fund, reducing the amount compared to v2. Other provisions, including those related to pediatric cancer drug investigations and orphan drug exclusivity, remain unchanged.
Overview
A handful of changes across two sections. · v3 refines the bill's identity by renaming it and adjusts a specific funding allocation, representing a narrowing of the proposed funding amount.
The most significant change in v3 is the renaming of the bill to the "Mikaela Naylon Give Kids a Chance Act," adding a specific dedication. Additionally, the proposed allocation for the Medicare Improvement Fund in Section 11 has been revised downwards from $3,047,000,000 for fiscal year 2027 in v2 to $2,622,000,000 in v3, without explicitly stating the fiscal year. All other substantive provisions related to pediatric cancer drug research, orphan drugs, and organ transplantation remain identical between the two versions.
Modifications
This change primarily affects the official designation and public identity of the bill, adding a personal dedication. It has no direct operative policy impact on the bill's provisions.
Before
The bill was titled the "Give Kids a Chance Act of 2025".
After
The bill is now titled the "Mikaela Naylon Give Kids a Chance Act".
This is a technical, conforming change that ensures consistency with the new short title. It does not alter the substance or duration of the sunset provision for organ procurement and transplantation network registration fees.
Before
The sunset clause for registration fees referred to the "Give Kids a Chance Act of 2025".
After
The sunset clause now refers to the "Mikaela Naylon Give Kids a Chance Act".
This modification reduces the proposed increase to the Medicare Improvement Fund. The final amount proposed by v3 ($2,622,000,000) is lower than the amount proposed by v2 ($3,047,000,000). This impacts the funding available for Medicare improvements. The absence of a fiscal year change in v3's amendment suggests that the fiscal year update might have been handled elsewhere or is implicitly understood.
Before
v2 amended Section 1898(b)(1) of the Social Security Act to change the fiscal year from "2026" to "2027" and the fund amount from "$1,804,000,000" to "$3,047,000,000".
After
v3 amends Section 1898(b)(1) of the Social Security Act by striking "$1,403,000,000" and inserting "$2,622,000,000".
Scope
Minor adjustment within existing scope — Changes are limited to the bill's short title and a specific funding allocation, with one consequential technical update. — v3 represents a refinement of the bill's identity and a specific adjustment to a funding amount, rather than a change in the overall policy direction of the bill. The core policy objectives remain consistent. — The change to the short title in Section 1(a) necessitates a conforming update in Section 8(d)(6). The change in Section 11 affects the specific dollar amount for the Medicare Improvement Fund but does not alter the fund's purpose or the mechanism for its allocation.
Impact analysis
The general public and stakeholders referring to the bill
Procedural change (renaming).
The official name of the bill has changed.
Medicare beneficiaries and the healthcare system
Negative financial impact (reduced funding compared to v2's proposal).
The proposed allocation for the Medicare Improvement Fund has been reduced.